Table 1.

Genomic signatures included in the study

Number of genesPatients with the signature classified as (%)*
First authorPrognosisOriginal signatureAvailable genes (%)PoorUncertaintyGoodReference
AzizOS1915 (78.9%)201 (23.5%)349 (40.8%)305 (35.7%)(42)
ChangDFS9595 (100.0%)341 (39.9%)299 (35%)215 (25.1%)(9)
ChenOS76 (85.7%)293 (34.3%)265 (31%)297 (34.7%)(12)
ShiDFS99 (100.0%)396 (46.3%)300 (35.1%)159 (18.6%)(43)
XuOS1513 (86.7%)299 (35%)492 (57.5%)64 (7.5%)(44)
MinhDFS7774 (96.5%)358 (41.9%)366 (42.8%)131 (15.3%)(45)
ShenDFS4532 (71.1%)335 (39.2%)338 (39.5%)182 (21.3%)(46)
TeodoroDFS44 (100.0%)0 (0.0%)855 (100%)0 (0.0%)(47)
AgesenDFS1313 (100.0%)74 (8.7%)688 (80.5%)93 (10.9%)(10)
PopoviciDFS6456 (87.5%)333 (38.9%)140 (16.4%)382 (44.7%)(14)
SeveenDFS77 (100.0%)140 (16.4%)598 (69.9%)117 (13.7%)(48)
MerlosDFS264247 (93.6%)156 (18.2%)235 (27.5%)464 (54.3%)(23)
OhDFS, OS8781 (93.1%)278 (32.5%)269 (31.5%)308 (36%)(13)
SalazarDFS1816 (88.9%)192 (22.5%)326 (38.1%)337 (39.4%)(49)
KaladyDFS, OS3624 (66.7%)245 (28.7%)429 (50.2%)181 (21.2%)(50)
PengDFS87 (87.5%)120 (14%)453 (53%)282 (33%)(51)
ToshiakiDFS109 (90.0%)323 (37.8%)232 (27.1%)300 (35.1%)(52)
FritzmannDFS113100 (88.5%)568 (66.4%)166 (19.4%)121 (14.2%)(27)
HaoDFS44 (100.0%)188 (22%)577 (67.5%)90 (10.5%)(53)
JorissenDFS122102 (83.6%)370 (43.3%)231 (27%)254 (29.7%)(53)
SmithDFS, OS3429 (85.3%)337 (39.4%)395 (46.2%)123 (14.4%)(11)
WatanabeDFS3122 (71.0%)156 (18.2%)432 (50.5%)267 (31.2%)(54)
GarmanDFS, OS4637 (80.4%)193 (22.6%)336 (39.3%)326 (38.1%)(55)
JiangDFS76 (85.7%)216 (25.3%)372 (43.5%)267 (31.2%)(26)
LinaDFS1614 (87.5%)141 (16.5%)518 (60.6%)196 (22.9%)(56)
LinbDFS2218 (81.8%)319 (37.3%)324 (37.9%)212 (24.8%)(56)
WangDFS1919 (100.0%)226 (26.4%)507 (59.3%)122 (14.3%)(46)
  • *Patients were classified as good, poor, or uncertain by the respective published genomic signatures based on prediction results (FDR <0.05) of the NTP.